Central serous retinopathy associated with topical oral corticosteroid use: a case report.
Autor: | O'Brien P; Austin Retina Associates, 801 W. 38th St., Suite 200, Austin, TX, 78705, USA. pobrien@austinretina.com., Young RC; Austin Retina Associates, 801 W. 38th St., Suite 200, Austin, TX, 78705, USA. ryoung@austinretina.com.; Department of Surgery and Perioperative Care, Dell Medical School, University of Texas, Austin, USA. ryoung@austinretina.com., Ghafoori SD; Austin Retina Associates, 801 W. 38th St., Suite 200, Austin, TX, 78705, USA. sday@austinretina.com.; Department of Surgery and Perioperative Care, Dell Medical School, University of Texas, Austin, USA. sday@austinretina.com., Harper CA; Austin Retina Associates, 801 W. 38th St., Suite 200, Austin, TX, 78705, USA. charper@austinretina.com.; Department of Surgery and Perioperative Care, Dell Medical School, University of Texas, Austin, USA. charper@austinretina.com., Wong RW; Austin Retina Associates, 801 W. 38th St., Suite 200, Austin, TX, 78705, USA. rwong@austinretina.com.; Department of Surgery and Perioperative Care, Dell Medical School, University of Texas, Austin, USA. rwong@austinretina.com. |
---|---|
Jazyk: | angličtina |
Zdroj: | Journal of medical case reports [J Med Case Rep] 2019 Jul 02; Vol. 13 (1), pp. 201. Date of Electronic Publication: 2019 Jul 02. |
DOI: | 10.1186/s13256-019-2143-3 |
Abstrakt: | Background: Oral topical corticosteroid gels are widely used in dental medicine. Case studies of central serous retinopathy have been reported following administration of corticosteroids, but none so far coinciding with the use of topical fluocinonide gel. This case report further contributes to the database of potential risks of corticosteroid use. Case Presentation: A 40-year-old South Asian woman presented with decreased vision, pigment epithelial detachments, and serous retinal detachments in both eyes 1 month after starting treatment with topical fluocinonide 0.05%, a topical oral corticosteroid gel. Her condition resolved 6 months after discontinuing the use of the steroid. Conclusions: To the best of our knowledge, this is the first case of idiopathic central serous retinopathy associated with the use of oral fluocinonide gel. Discontinuing the use of the steroid may result in resolution of the serous retinal detachment and improvement of visual symptoms. Patients and their doctors who prescribe this medication should be aware of this association. |
Databáze: | MEDLINE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |